Ortho Dermatologics, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced that the Journal of the American Academy of Dermatology (JAAD) published for the first …
Ortho Dermatologics, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced it has submitted a New Drug Application (NDA) to the FDA for IDP-118 (halobetasol propionate …